Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyKlas Kärre(Karolinska Institutet), Rolf Kiessling(Karolinska University Hospital)NatureFebruary 20, 198610.1038/319675a0Cited by 2,140SaveCiteExport RISWatch citationsRelated PapersImmature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign|Cancer Research|2010|377Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity|The Journal of Immunology|2015|212